Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    18471707 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Circulating Tumor Cells in Operative Blood
Condition: Carcinoma, Pancreatic Ductal
Interventions: Procedure: Peripheral/Central Venous Blood Draw;   Procedure: Peritoneal Wash
2 Recruiting Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas (PC04)
Condition: Pancreatic Cancer
Interventions: Radiation: Proton Radiation;   Drug: Capecitabine;   Procedure: Surgical resection;   Behavioral: FACT-Hep questionnaire
3 Recruiting Pancreas Cancer: Molecular Profiling as a Guide to Therapy Before and After Surgery ("Personalized Medicine")
Condition: Pancreatic Adenocarcinoma
Interventions: Drug: Targeted chemotherapy prior to surgery;   Drug: standard FOLFIRINOX chemotherapy prior to surgery;   Drug: Gemcitabine after surgery;   Other: No additional therapy after surgery;   Drug: Targeted chemotherapy after surgery;   Radiation: Chemoradiotherapy (cXRT)

Study has passed its completion date and status has not been verified in more than two years.